Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data & AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Power List / 2018 / Power List / Matthew J Baker

Matthew J. Baker

Reader in Chemistry, Department of Pure and Applied Chemistry, University of Strathclyde, UK.

  • Profile

Meet Matthew J. Baker

Research
My focus is to impact upon people’s lives by understanding the composition and behavior of molecules in complex media. I aim to detect or identify disease, toxic chemicals and pathogenic bacteria via spectroscopy and translate these methods to real-world settings.

Greatest achievement
In January of this year we were able to put a FTIR spectrometer in the Western General Hospital, Edinburgh, that is fitted with the new accessories that we have developed via my spinout (www.clinspecdx.com). We were able to collect serum spectroscopic data from people attending for a CT, finally translating something invented in the lab to the clinic.

Objective
I hope to have fully regulated spectroscopic tests that are FDA/MHRA approved, used in daily practice and cover a wide range of diseases. This will not only benefit patients but also expand our field.

Prediction
The infrared spectroscopy area is very interesting at the moment with the use of new light sources and new techniques coming, such as nanoscale IR and thermal-based analysis.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.